TMEM220 and malignant colon neoplasm: CDKN2B-AS1 and TMEM220-AS1 were significantly downregulated in colon cancer, whereas LINC02257, PCAT1, and CASC8 were significantly upregulated in colorectal cancer (Fig 3).